Photodynamic therapy for neovascular age-related macular degeneration

Age-related macular degeneration

“…29,30 Severe adverse events associated with the procedure include visual disturbance and vision loss (2.6%), injection site events (13.1%), infusion-related back pain (2.4%) and photosensitivity reactions (2.4%). 31,32 Results with this technique were marginally better compared to previous techniques. It moderately reduces further vision loss but only rarely improves visual acuity.…”

Age-related macular degeneration

“…29,30 Severe adverse events associated with the procedure include visual disturbance and vision loss (2.6%), injection site events (13.1%), infusion-related back pain (2.4%) and photosensitivity reactions (2.4%). 31,32 Results with this technique were marginally better compared to previous techniques. It moderately reduces further vision loss but only rarely improves visual acuity.…”

Photodynamic therapy with verteporfin accelerates apoptotic bleb formation in human ameloblastoma

“…Although VP PDT is clinically performed in patients with age‐related macular degeneration (Wormald et al., 2007), the side effects of VP, such as allergic reactions and infusion‐associated back pain (Borodoker et al., 2002) should not be underestimated. Although a previous open‐label, randomized, multicenter, dose‐ranging phase 2 study showed that a single course of VP PDT benefited patients with multiple non‐melanoma skin cancers (Lui et al., 2004), most reports suggesting an anti‐tumor effect of VP PDT are based on experiments using cultured cells and animals and there is little evidence on the effect of VP PDT.…”

Validation and comparison of five preference-based measures among age-related macular degeneration patients: evidence from mainland China

“…The capability approach offers an alternative to HRQoL, where an individual's ability or capability to function is the outcome evaluated [51]. AMD may limit individuals' ability to live fulfilling lives, but a successful surgery (i.e., photodynamic therapy) could reduce limitations caused by impaired vision [52,53]. The empirical relationships with CLVQoL subscales suggest that 15D and EQ-5D-5L were Fig.…”

Age-related macular degeneration

“…29,30 Severe adverse events associated with the procedure include visual disturbance and vision loss (2.6%), injection site events (13.1%), infusion-related back pain (2.4%) and photosensitivity reactions (2.4%). 31,32 Results with this technique were marginally better compared to previous techniques. It moderately reduces further vision loss but only rarely improves visual acuity.…”

Photodynamic therapy with verteporfin accelerates apoptotic bleb formation in human ameloblastoma

“…Although VP PDT is clinically performed in patients with age‐related macular degeneration (Wormald et al., 2007), the side effects of VP, such as allergic reactions and infusion‐associated back pain (Borodoker et al., 2002) should not be underestimated. Although a previous open‐label, randomized, multicenter, dose‐ranging phase 2 study showed that a single course of VP PDT benefited patients with multiple non‐melanoma skin cancers (Lui et al., 2004), most reports suggesting an anti‐tumor effect of VP PDT are based on experiments using cultured cells and animals and there is little evidence on the effect of VP PDT.…”

Validation and comparison of five preference-based measures among age-related macular degeneration patients: evidence from mainland China

“…The capability approach offers an alternative to HRQoL, where an individual's ability or capability to function is the outcome evaluated [51]. AMD may limit individuals' ability to live fulfilling lives, but a successful surgery (i.e., photodynamic therapy) could reduce limitations caused by impaired vision [52,53]. The empirical relationships with CLVQoL subscales suggest that 15D and EQ-5D-5L were Fig.…”

Age-related macular degeneration

“…29,30 Severe adverse events associated with the procedure include visual disturbance and vision loss (2.6%), injection site events (13.1%), infusion-related back pain (2.4%) and photosensitivity reactions (2.4%). 31,32 Results with this technique were marginally better compared to previous techniques. It moderately reduces further vision loss but only rarely improves visual acuity.…”

Photodynamic therapy with verteporfin accelerates apoptotic bleb formation in human ameloblastoma

“…Although VP PDT is clinically performed in patients with age‐related macular degeneration (Wormald et al., 2007), the side effects of VP, such as allergic reactions and infusion‐associated back pain (Borodoker et al., 2002) should not be underestimated. Although a previous open‐label, randomized, multicenter, dose‐ranging phase 2 study showed that a single course of VP PDT benefited patients with multiple non‐melanoma skin cancers (Lui et al., 2004), most reports suggesting an anti‐tumor effect of VP PDT are based on experiments using cultured cells and animals and there is little evidence on the effect of VP PDT.…”

Validation and comparison of five preference-based measures among age-related macular degeneration patients: evidence from mainland China

“…The capability approach offers an alternative to HRQoL, where an individual's ability or capability to function is the outcome evaluated [51]. AMD may limit individuals' ability to live fulfilling lives, but a successful surgery (i.e., photodynamic therapy) could reduce limitations caused by impaired vision [52,53]. The empirical relationships with CLVQoL subscales suggest that 15D and EQ-5D-5L were Fig.…”